Medegen, Inc
Advised Medegen, Inc., a medical device company that develops, manufactures and markets clinically superior disposable intravenous therapy products on its sale to CareFusion, a global medical devices company
Advised Medegen, Inc., a medical device company that develops, manufactures and markets clinically superior disposable intravenous therapy products on its sale to CareFusion, a global medical devices company
Advised Heartscape Technologies, a medical device company on its sale of substantially all its assets to Roper Industries, a diversified growth company
Advised Bucyrus International, Inc., a global mining equipment manufacturer, on the acquisition of the mining division of Terex Corp., a diversified equipment company
Advised Wells Fargo on the acquisition of Prudential Financial’s noncontrolling interest in their retail brokerage Joint Venture
Advised Fleetwood Enterprises, Inc. on the sale of substantially all of its assets, pursuant to multiple Section 363 sales
Advised the Pension Benefit Guaranty Corporation ("PBGC") on Delphi’s reorganization and the structure and terms of the PBGC’s recovery on account of Delphi’s pension plan termination
Advised ICT Group on its merger with Sykes Enterprises, both leading global providers of outsourced customer contact management solutions and services
Advised NCI Building Systems, Inc., one of North America’s largest integrated manufacturers and marketers of metal products for the non-residential construction industry, on its financial restructuring, which included a majority investment by CD&R and a restructuring of NCI’s outstanding debt
Advised PartnerRe Ltd., a leading global reinsurer, providing multi-line reinsurance to insurance companies, on its acquisition of PARIS RE Holdings Ltd., a French-listed, Swiss-based diversified reinsurer
Advised LabCorp on the acquisition of Monogram Biosciences, a molecular diagnostics company focused on guiding and improving the treatment of serious infectious diseases and cancer